Serbia to Lower Medication Costs for Citizens on Regular Therapy

President Aleksandar Vučić of Serbia has announced a series of measures designed to significantly reduce the cost of medications for all citizens receiving regular therapy. This initiative aims to ease the financial burden on individuals managing chronic conditions or requiring ongoing treatment. The announcement signals a government effort to make essential medicines more accessible and affordable.

The implemented measures will focus on lowering the prices of specific medications, ensuring that those who rely on consistent pharmaceutical care can access their treatments more easily. President Vučić stated that these reductions are part of a broader effort to improve the healthcare system and enhance the quality of life for Serbian citizens. The policy is set to take effect soon, providing immediate relief to many.

However, the price reductions are currently slated to last for one year. This temporary nature of the policy raises questions about its long-term sustainability and the government's future plans for pharmaceutical pricing. While the immediate impact is expected to be positive for patients, the one-year limitation suggests a need for ongoing evaluation and potential adjustments to ensure continued affordability and availability of medicines in Serbia.